Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases-Reference-Cited by-同舟云学术

Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases

Published:2017-12-11 Issue:1 Volume:38 Page:6-18
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Maura Géric¹²^ORCID,Billionnet Cécile¹,Alla François¹,Gagne Joshua J.³,Pariente Antoine²⁴

Affiliation:

1. Department of Studies in Public Health; French National Health Insurance (Assurance Maladie/CNAMTS-TS); Paris Cedex 20 France

2. Bordeaux Population Health Research Center; Team PHARMACOEPIDEMIOLOGY-UMR 1219; University of Bordeaux, INSERM; Bordeaux France

3. Division of Pharmacoepidemiology and Pharmacoeconomics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

4. Pharmacologie; CHU de Bordeaux; Bordeaux France

Publisher

Wiley

Subject

Pharmacology (medical)

Reference49 articles.

1. Worldwide epidemiology of atrial aibrillation: a global burden of disease 2010 study;Chugh;Circulation,2014

2. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Guyatt;Chest,2012

3. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

4. Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence;Broderick;Stroke,2011

5. Warfarin discontinuation after starting warfarin for atrial fibrillation;Fang;Circ Cardiovasc Qual Outcomes,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do Proton Pump Inhibitors Reduce Upper Gastrointestinal Bleeding in Older Patients with Atrial Fibrillation Treated with Oral Anticoagulants? A Nationwide Cohort Study in France;Drugs & Aging;2023-12-20

2. Oral anticoagulant switching in patients with atrial fibrillation: a scoping review;BMJ Open;2023-04

3. Comparative non-persistence in the first year of treatment with oral anticoagulants in patients with atrial fibrillation: A French comprehensive nationwide study;Archives of Cardiovascular Diseases;2022-11

4. Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation;Journal of Clinical Medicine;2022-10-12

5. Skin adverse reactions to direct oral anticoagulants in patients referred to dermatology-allergology departments of the FISARD group (French Investigators for Skin Adverse Reactions to Drugs);Annales de Dermatologie et de Vénéréologie;2022-09